Position in XNCR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,670,149
+$419,093 QoQ
Shares Held
103,736
0.0% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#58
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DCF Advisers, LLC holds $72,469,035 across 22 Biotechnology names. XNCR ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
14,200 | $13,174,334 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
637,500 | $9,524,250 | |
| 3 | HELP |
Cybin Inc.
|
1,434,988 | $9,485,270 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,250 | $5,767,745 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,500 | $5,712,395 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
141,000 | $4,778,490 | |
| 7 | INCY |
Incyte Corp
|
41,500 | $4,704,440 | |
| 8 | IMRX |
Immuneering Corp
|
790,000 | $3,942,100 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,670,149 | 103,736 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,251,056 | 103,736 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,369,008 | 154,736 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,225,603 | 189,736 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,100,400 | 140,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,151,056 | 202,167 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,668,777 | 203,167 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,212,622 | 209,479 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,955,972 | 208,979 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,624,705 | 208,979 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,033,781 | 237,107 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,962,945 | 246,300 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,368,550 | 215,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,856,900 | 210,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,363,536 | 205,973 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,022,164 | 231,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,837,026 | 249,800 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,856,760 | 257,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,699,531 | 241,763 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,511,800 | 230,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,794,530 | 197,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,181,400 | 190,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,715,092 | 199,750 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,311,915 | 188,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,165,987 | 190,367 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,509,920 | 84,000 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||